GlassScriptPhysician profile
Ching-Wei D Tzeng
NPI 1164636908
$5,669.83
in general payments reported to CMS, 2019-2025
11 companies · $1,294 in 2025
The $1,294 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,157 · 2020: $176 · 2021: $1,515 · 2022: $529 · 2023: $312 · 2024: $688 · 2025: $1,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,293.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $2,228.75 | 2021-2025 | Echelon Endopath, Dermabond Prineo, Enseal |
| Intuitive Surgical, INC. | $1,003.22 | 2019 | |
| Medtronic, INC. | $831.11 | 2022-2024 | Signia, Emprint, Endurant Iis |
| Integra Lifesciences Corporation | $614.16 | 2019-2025 | Codman Certas, Cusa Clarity, Codman Hakim |
| Dilon Technologies, INC. | $475.22 | 2025 | Hemoblast Bellows |
| Intera Oncology, INC | $155.92 | 2025 | Intera |
| Jazz Pharmaceuticals INC. | $128.00 | 2025 | |
| Medical Device Business Services, INC. | $125.42 | 2025 | Enseal, Vistaseal |
| Angiodynamics, INC. | $87.05 | 2019 | |
| Hitachi Healthcare Americas Corp. | $20.98 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ching-Wei Tzeng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.